ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,629Medicare Part D Prescriptions Filled, Including Refills

Rank: 51 out of 1111

$1.21M Total Retail Price of All Prescriptions

Rank: 25 out of 1111

584 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
66% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 584 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

27% of this provider’s 584 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

2% of this provider’s 12,664 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$73 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
HYDROCODONE-ACETAMINOPHEN 777 458 S3 1 1
LEVOTHYROXINE SODIUM 561 491 2 3
LISINOPRIL 528 402 3 2
OMEPRAZOLE 516 419 4 4
AMLODIPINE BESYLATE 425 354 5 7
METOPROLOL TARTRATE 415 341 6 12
FUROSEMIDE 414 371 7 6
SIMVASTATIN 382 318 8 5
HYDROCHLOROTHIAZIDE 327 225 9 11
METFORMIN HCL 319 221 10 8
POTASSIUM CHLORIDE 308 261 11 9
NAMENDA 304 289 12 31
GABAPENTIN 277 215 13 10
FLUOXETINE HCL 273 229 14 44
ATORVASTATIN CALCIUM 258 222 15 15
WARFARIN SODIUM 235 195 16 19
EXELON 190 185 17 121
CITALOPRAM HBR 189 131 18 14
CLOPIDOGREL 174 159 19 30
POLYETHYLENE GLYCOL 3350 169 133 20 45
MORPHINE SULFATE ER 166 89 S2 21 74
ATENOLOL 146 108 22 22
LANTUS 141 89 23 46
NEXIUM 138 93 24 26
METOPROLOL SUCCINATE 136 128 25 20
LOSARTAN POTASSIUM 129 121 26 34
RISPERIDONE 128 75 27 60
TRAMADOL HCL 126 102 28 13
HUMULIN R 118 79 29 189
CARVEDILOL 116 113 30 21
PLAVIX 114 102 31 49
MEGESTROL ACETATE 113 106 R 32 103
DONEPEZIL HCL 112 108 33 25
PANTOPRAZOLE SODIUM 111 87 34 50
SERTRALINE HCL 111 55 34 24
LEVEMIR 110 71 36 132
PRAVASTATIN SODIUM 109 95 37 17
DIGOXIN 107 95 38 47
SULFAMETHOXAZOLE-TRIMETHOPRIM 105 84 39 71
JANTOVEN 102 42 40 156
ZOLPIDEM TARTRATE 101 58 41 16
CLONIDINE HCL 98 68 42 42
ALLOPURINOL 93 56 43 36
FLUTICASONE PROPIONATE 90 69 44 27
DICLOFENAC SODIUM 89 82 45 108
ISOSORBIDE MONONITRATE ER 89 82 45 73
TAMSULOSIN HCL 86 63 47 28
FENTANYL 85 63 S2 48 65
PAROXETINE HCL 84 60 49 55
PREDNISONE 82 69 50 48
BENZTROPINE MESYLATE 82 22 R 50 169
KLOR-CON M20 81 77 52 79
PROPRANOLOL HCL 77 73 53 124
CEFUROXIME 76 66 54 138
ESCITALOPRAM OXALATE 75 56 55 78
NOVOLIN R 73 55 56 142
QUETIAPINE FUMARATE 72 55 57 76
ADVAIR DISKUS 71 48 58 43
PROAIR HFA 70 42 59 38
DIVALPROEX SODIUM 70 55 59 82
CARBIDOPA-LEVODOPA 70 41 59 101
RANITIDINE HCL 69 52 62 29
ENALAPRIL MALEATE 66 49 63 56
ALENDRONATE SODIUM 65 52 64 35
INSULIN SYRINGE 65 43 64 167
PHENYTOIN SODIUM EXTENDED 64 16 66 126
NOVOLOG 63 38 67 104
SUCRALFATE 61 53 68 125
DOXAZOSIN MESYLATE 60 55 69 87
MIRTAZAPINE 59 52 70 52
TRAZODONE HCL 59 52 70 32
ACTOS 58 54 72 98
CRESTOR 57 50 73 33
OXYBUTYNIN CHLORIDE ER 56 46 74 114
SPIRONOLACTONE 56 47 74 83
GENERLAC 54 40 76 203
PHENYTOIN 54 38 76 272
OLANZAPINE 53 41 78 117
ABILIFY 51 25 79 123
EVISTA 50 50 80 148
LEVETIRACETAM 50 27 80 111
MELOXICAM 50 37 80 18
OXYCONTIN 50 14 S2 80 106
OXYBUTYNIN CHLORIDE 50 41 80 110
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 30, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.